We are live on ! Find out more
RNLX

Renalytix plc American Depositary Shares

Delisted

RNLX was delisted on the 7th of October, 2024.

22 hedge funds and large institutions have $6.46M invested in Renalytix plc American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more capital invested

Capital invested by funds: $5.65M → $6.46M (+$810K)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

19% less funds holding

Funds holding: 2722 (-5)

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

53% less call options, than puts

Call options by funds: $15K | Put options by funds: $32K

Holders
22
Holders Change
-5
Holders Change %
-18.52%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
6
Reduced
7
Closed
10
Calls
$15K
Puts
$32K
Net Calls
-$17K
Net Calls Change
+$24K

RNLX Hedge Fund Activity: Q4 2022 in Review

22 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q4 2022, worth a combined $6.46M — up 14% from $5.65M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of RNLX and 6 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 6 added.

The largest buyer was Pinnacle Associates, adding an estimated $190K. The largest seller was Fred Alger Management, exiting entirely with an estimated $394K sold.

  • 22 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q4 2022, down from 27 in Q3 2022.
  • Funds reported $6.46M of Renalytix plc American Depositary Shares stock for Q4 2022, up 14% quarter-over-quarter.
  • 6 funds opened new Renalytix plc American Depositary Shares positions in Q4 2022 and 10 closed out, a net change of -4 holders.
  • The largest Renalytix plc American Depositary Shares buyer in Q4 2022 was Pinnacle Associates, an estimated $190K added.
  • The largest Renalytix plc American Depositary Shares seller in Q4 2022 was Fred Alger Management, an estimated $394K sold.

Based on aggregated 13F filings for Q4 2022.